Tell me base line tests in first trimester pregnancy
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
first trimester baseline tests antenatal investigations ACOG WHO guidelines 2024
Finding Sources
Reading Web Page
first trimester baseline tests antenatal investigations
Finding Sources
Finding Sources
I've exhausted DB queries. I have strong data from ACOG guidelines (via StatPearls/NCBI) and web sources. Let me now compose a thorough, well-organized answer.
First Trimester Baseline Tests in Pregnancy
The first prenatal visit (ideally at 8-10 weeks) establishes baseline maternal-fetal health, confirms dating, identifies high-risk pregnancies, and initiates screening. Here is a complete breakdown:
1. Hematological Tests
| Test | Purpose |
|---|---|
| Complete Blood Count (CBC) | Screen for anemia, thrombocytopenia, leukocytosis |
| Blood group (ABO & RhD typing) | Identify Rh-negative mothers needing anti-D prophylaxis |
| Antibody screen (indirect Coombs) | Detect alloantibodies that could cause hemolytic disease of the fetus/newborn (HDFN) |
| Hemoglobin electrophoresis | Screen for sickle cell disease, thalassemia (in at-risk populations) |
2. Infectious Disease Screening
| Test | Pathogen / Purpose |
|---|---|
| Rubella IgG serology | Assess immunity; non-immune patients counselled on post-partum vaccination |
| Hepatitis B surface antigen (HBsAg) | Identify carriers to enable neonatal prophylaxis (HBIG + vaccine at birth) |
| Hepatitis C antibody (anti-HCV) | Universal screening recommended (USPSTF Grade B) |
| HIV serology | Opt-out universal screening; enables PMTCT (prevention of mother-to-child transmission) |
| Syphilis serology (RPR/VDRL + TPPA) | Prevents congenital syphilis; mandatory in most jurisdictions |
| Gonorrhoea & Chlamydia (NAAT) | Cervical/vaginal swab, especially in women <25 or at risk |
| Varicella IgG | If history of chickenpox is uncertain |
| Toxoplasma IgG/IgM | Recommended in some countries (France, Eastern Europe); selective in UK/US |
| TB screen (Mantoux/IGRA) | Indicated if risk factors present (endemic area, HIV, close contact) |
3. Urine Tests
| Test | Purpose |
|---|---|
| Urinalysis (dipstick) | Detect proteinuria, glucosuria, haematuria, leucocytes |
| Urine culture (midstream) | Screen for asymptomatic bacteriuria (12-16 weeks or first visit) - treating reduces risk of pyelonephritis and preterm birth |
4. Biochemical / Metabolic Tests
| Test | Purpose |
|---|---|
| Fasting glucose or HbA1c | Screen for pre-existing (type 2) diabetes in high-risk women; universal in some guidelines |
| Thyroid function (TSH) | Selective screening in symptomatic women, those with goitre, personal/family history of thyroid disease |
| Serum ferritin | Assess iron stores if anemia is present on CBC |
| Vitamin D (25-OH vitamin D) | In at-risk groups (dark skin, veiled, minimal sun exposure, BMI >30) |
| Urine protein:creatinine ratio | If proteinuria on dipstick |
5. Genetic / Chromosomal Screening (First Trimester)
These are offered (not mandatory) and require informed consent:
| Test | Timing | What It Screens |
|---|---|---|
| Combined first-trimester screening | 11-14 weeks | Trisomy 21, 18, 13 - includes NT ultrasound + serum PAPP-A + free beta-hCG |
| Cell-free fetal DNA (cfDNA / NIPT) | ≥10 weeks | High sensitivity/specificity for trisomies 21, 18, 13; sex chromosome aneuploidies |
| Nuchal translucency (NT) ultrasound | 11+0 to 13+6 weeks | Part of combined screening; also detects major structural abnormalities |
6. Cervical Screening
| Test | Indication |
|---|---|
| Cervical smear (Pap test) | If overdue per national schedule; defer if not due |
| Cervical length measurement (TVS) | In women with prior preterm birth or cervical surgery |
7. Blood Pressure & Physical Measurements
- Baseline blood pressure - essential to classify hypertensive disorders later (USPSTF recommendation at every visit)
- Height and weight (BMI) - guides supplementation dosing, VTE risk, anesthesia planning
- Fundal height - for gestational age confirmation if late presenter
8. Imaging
| Investigation | Timing | Purpose |
|---|---|---|
| First trimester ultrasound | 7-14 weeks | Confirm intrauterine pregnancy, viability, crown-rump length (gestational age), chorionicity in twins, nuchal translucency |
| Dating ultrasound | Ideally 8-10 weeks | Establish EDD (more accurate than LMP if cycles irregular) |
9. Additional Risk-Based Tests
These are added based on individual risk factors:
- Lead level - if environmental/occupational exposure
- Thrombophilia screen (Factor V Leiden, prothrombin mutation, antiphospholipid antibodies) - prior DVT/PE, recurrent miscarriage
- Anti-Ro/La antibodies - women with lupus or Sjogren's (risk of fetal heart block)
- HTLV-1 antibody - endemic regions (Japan, Caribbean, West Africa)
- Malaria screen - endemic regions
Quick Reference Summary (ACOG Mandatory Panel)
CBC | ABO/RhD | Antibody screen | Rubella | Syphilis (RPR) | Hepatitis B (HBsAg) | Hepatitis C | HIV | Urine culture | Urine dipstick
These are universally recommended at the first prenatal visit regardless of risk status.
Sources: ACOG Practice Guidelines (2024 update); USPSTF recommendations; StatPearls - Initial Antepartum Care; Creasy & Resnik's Maternal-Fetal Medicine; Berek & Novak's Gynecology
This is a shared conversation. Sign in to Orris to start your own chat.